↓ Skip to main content

The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification

Overview of attention for article published in Cancer Imaging, April 2014
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification
Published in
Cancer Imaging, April 2014
DOI 10.1186/1470-7330-14-13
Pubmed ID
Authors

Alexandre Cochet, Steven David, Kate Moodie, Elizabeth Drummond, Gaelle Dutu, Michael MacManus, Boon Chua, Rodney J Hicks

Abstract

The incremental value of 18FDG PET/CT in patients with breast cancer (BC) compared to conventional imaging (CI) in clinical practice is unclear. The aim of this study was to evaluate the management impact and prognostic value of 18 F-FDG PET/CT in this setting.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 5 26%
Other 2 11%
Researcher 2 11%
Student > Master 1 5%
Student > Bachelor 1 5%
Other 2 11%
Unknown 6 32%
Readers by discipline Count As %
Medicine and Dentistry 9 47%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Chemistry 1 5%
Engineering 1 5%
Unknown 7 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2015.
All research outputs
#20,656,161
of 25,373,627 outputs
Outputs from Cancer Imaging
#445
of 674 outputs
Outputs of similar age
#177,854
of 241,520 outputs
Outputs of similar age from Cancer Imaging
#10
of 15 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 674 research outputs from this source. They receive a mean Attention Score of 2.4. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,520 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.